Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Malaysian device system targets total life cycle regulation

This article was originally published in Clinica

Executive Summary

Malaysia’s one-year transition to a new risk-based medical device regulatory system – founded in GHTF concepts and designed to facilitate trade as well as ensuring quality and safety – is well under way. The first deadline (compliance with Act 738 - Medical Device Establishment Act) ended on 1 July 2014. Medical Device Authority (MDA) chief executive Zamane bin Abdul Rahman outlined the new regulatory requirements, and who is affected, at the recent Informa Life Sciences Asia Pacific conference

Advertisement

Related Content

Topics

Advertisement
UsernamePublicRestriction

Register

MT101716

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel